Arjan V. D. L.
- Country
- The Netherlands
- Department
- Hematology
Research Overview
- Phase 1 Evaluation of Allo-RevCAR01-T-CD123 in CD123 Positive Hematologic Malignancies, Including Acute Myeloid Leukemia (AML)
- A Phase 3b, open-label, single-arm, rollover study to evaluate long-term safety in subjects who have participated in other luspatercept (ACE-536, also known as BMS 986346) clinical trials.
- A Phase 3, Open -label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions.
Data & Insights
Has run more than one trial at 4 of 79 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating complex blood disorders, with particular emphasis on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Their research encompasses innovative therapeutic approaches for patients with various risk levels of these conditions.
- Transfusion-dependent MDS
- ESA-refractory blood disorders
- CD123-positive malignancies
The investigator's work extends to studying disease progression patterns and exploring novel treatment options for patients who have not responded to conventional therapies.
Cell-Based Therapies
The investigator focuses on developing and evaluating advanced cellular treatments, including allogeneic CAR-T cell therapy. Their expertise includes targeting specific molecular markers in hematologic cancers.
- Novel immunotherapy approaches
- Targeted cellular treatments
- Molecular marker identification
Their research interests encompass the development of personalized treatment strategies for patients with advanced blood cancers.
Treatment Resistance
The investigator has developed expertise in addressing treatment-resistant blood disorders, particularly focusing on patients who have failed standard therapeutic approaches.
- Refractory disease management
- Long-term survival strategies
- Disease progression monitoring
Their work includes evaluating new therapeutic options for patients with limited treatment alternatives.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.